Detection of the JAK2 V617F Mutation by LightCycler PCR and Probe Dissociation Analysis

A point mutation in the JAK2 gene, a member of the tyrosine kinase family, was recently identified and shown to be associated with several myeloproliferative disorders. Several studies identified the same JAK2 point mutation (1849G>T), resulting in the substitution of a valine to phenylalanine at...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of molecular diagnostics : JMD Vol. 8; no. 3; pp. 330 - 334
Main Authors Lay, Marla, Mariappan, Rajan, Gotlib, Jason, Dietz, Lisa, Sebastian, Siby, Schrijver, Iris, Zehnder, James L.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.07.2006
ASIP
American Society for Investigative Pathology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A point mutation in the JAK2 gene, a member of the tyrosine kinase family, was recently identified and shown to be associated with several myeloproliferative disorders. Several studies identified the same JAK2 point mutation (1849G>T), resulting in the substitution of a valine to phenylalanine at codon 617 (V617F). We developed a simple and sensitive method to detect this mutation via polymerase chain reaction and probe dissociation analysis using the LightCycler platform, and we compared this method to existing restriction fragment-length polymorphism, direct sequencing, and amplification refractory mutation system methods. We found that the LightCycler method offered advantages of speed, reliability, and more straightforward interpretation over the restriction fragment-length polymorphism and sequencing approaches.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Address reprint requests to James L. Zehnder, M.D., Department of Pathology, L235, 300 Pasteur Dr., Stanford University School of Medicine, Stanford, CA 94305.
ISSN:1525-1578
1943-7811
DOI:10.2353/jmoldx.2006.050130